New era for ME/CFS research as top cytokine study attracts media headlines
The immune systems of patients who have recently developed ME/CFS look markedly different from those who have been ill for much longer, according to a major new study from Drs. Ian Lipkin and Mady Hornig at Columbia University. This shift in immune function hadn’t been seen before.
Discuss the article on the Forums.

Anybody heard of VIP (Vasoactive Intestinal Peptide)?

Discussion in 'Addressing Biotoxin, Chemical & Food Sensitivities' started by InvertedTree, Aug 4, 2009.

  1. InvertedTree

    InvertedTree Senior Member

    This is a new treatment that (I think) Dr. Shoemaker developed. My doctor is having me try it.

    It's supposed to have immune modulating properties but I think it might be geared towards biotoxin related illness.

    It's a nasal spray from a compounding pharmacy.

    Just wondering if anybody has heard of this?
  2. Beady


    I have never heard the name earlier... But it made me think of something Dr. De Meirleir mentioned

    He mentioned once that there is a nasal spray that he can use as a last step on patients if there still are great symptoms when all the test results are ok after long-time treatments. As far as I understood, the spray he mentioned could "quick start" the hypothalamus so that sensory sensitivity and other symptoms disappear... But I think he considers it harmful to use it before other treatments and before tests is fine, since he finds the sensitivity to be an important defender that protects the body (by telling it to slow down) as long as there is reason for it

    I am of course not sure if this is the same as the one your doc are talking about, and I am not saying that dr. De Meirleirs theory is the right one even if it should be the same...

See more popular forum discussions.

Share This Page